Artificially engineered vesicular vehicles for targeted therapy
Vesicular vehicles have been one of the most potential platforms for therapeutic delivery. Here, we commentate on recent advances in the development of therapeutic vesicular delivery platforms, emphasizing two intriguing works, namely, the chimeric nanobody-decorated immunoliposomes (Wan et al.) and...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Extracellular Vesicle |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2773041724000143 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846115548459433984 |
|---|---|
| author | Zhigang Wang Yufei Yan Rui Li Ying Zhu Gen Yang |
| author_facet | Zhigang Wang Yufei Yan Rui Li Ying Zhu Gen Yang |
| author_sort | Zhigang Wang |
| collection | DOAJ |
| description | Vesicular vehicles have been one of the most potential platforms for therapeutic delivery. Here, we commentate on recent advances in the development of therapeutic vesicular delivery platforms, emphasizing two intriguing works, namely, the chimeric nanobody-decorated immunoliposomes (Wan et al.) and the retrovirus-like capsids incorporated extracellular vesicles (Jiang et al.). In the work of Wan et al., the researchers proposed a novel strategy for antitumor immunoliposome construction by the one-step self-assembly of lipids with rationally designed chimeric nanobody that comprises a nanobody against human epidermal growth factor receptor 2, a flexible peptide linker, and a human single transmembrane domain. By leveraging the natural cell systems (e.g., E coli.) to synthesize the chimeric nanobody, this technique provides a facile and robust strategy for producing immunoliposome platforms, ensuring suitability for industrial manufacturing and distribution, regulatory compliance, and clinical use. In the work of Jiang et al., taking advantage of the natural extracellular vesicle biogenesis system, the researchers introduced the activity-regulated cytoskeleton-associated protein inside the vesicle lumen and thus constructed endogenous retrovirus-like vesicles for mRNA drug delivery to neurons. This technique offers a significative strategy for developing sophisticated delivery platforms, manifesting broad application potential for different disease therapeutics. Overall, these two works have represented two typical paradigms for the artificial construction of vesicular vesicles. Considering their complementary merits, in the future, the integration of artificial engineering technologies and natural biosynthesis systems is anticipated to be a promising strategy to expedite the development of potent delivery systems. |
| format | Article |
| id | doaj-art-a7230d2fd5da4d169badf86aa96e2258 |
| institution | Kabale University |
| issn | 2773-0417 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Extracellular Vesicle |
| spelling | doaj-art-a7230d2fd5da4d169badf86aa96e22582024-12-19T11:03:19ZengElsevierExtracellular Vesicle2773-04172024-12-014100047Artificially engineered vesicular vehicles for targeted therapyZhigang Wang0Yufei Yan1Rui Li2Ying Zhu3Gen Yang4Corresponding author. Center of Biomedical Physics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325001, PR China.; Center of Biomedical Physics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325001, PR China; School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, 325035, PR ChinaCenter of Biomedical Physics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325001, PR ChinaCenter of Biomedical Physics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325001, PR China; Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, 325035, PR ChinaCenter of Biomedical Physics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325001, PR China; Postgraduate Training Base Alliance of Wenzhou Medical University, Wenzhou, 325035, PR ChinaCorresponding author. Center of Biomedical Physics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325001, PR China.; Center of Biomedical Physics, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325001, PR China; State Key Laboratory of Nuclear Physics and Technology, School of Physics, Peking University, Beijing, 100871, PR China; School of Public Health and Management, Wenzhou Medical University, Wenzhou, 325035, PR ChinaVesicular vehicles have been one of the most potential platforms for therapeutic delivery. Here, we commentate on recent advances in the development of therapeutic vesicular delivery platforms, emphasizing two intriguing works, namely, the chimeric nanobody-decorated immunoliposomes (Wan et al.) and the retrovirus-like capsids incorporated extracellular vesicles (Jiang et al.). In the work of Wan et al., the researchers proposed a novel strategy for antitumor immunoliposome construction by the one-step self-assembly of lipids with rationally designed chimeric nanobody that comprises a nanobody against human epidermal growth factor receptor 2, a flexible peptide linker, and a human single transmembrane domain. By leveraging the natural cell systems (e.g., E coli.) to synthesize the chimeric nanobody, this technique provides a facile and robust strategy for producing immunoliposome platforms, ensuring suitability for industrial manufacturing and distribution, regulatory compliance, and clinical use. In the work of Jiang et al., taking advantage of the natural extracellular vesicle biogenesis system, the researchers introduced the activity-regulated cytoskeleton-associated protein inside the vesicle lumen and thus constructed endogenous retrovirus-like vesicles for mRNA drug delivery to neurons. This technique offers a significative strategy for developing sophisticated delivery platforms, manifesting broad application potential for different disease therapeutics. Overall, these two works have represented two typical paradigms for the artificial construction of vesicular vesicles. Considering their complementary merits, in the future, the integration of artificial engineering technologies and natural biosynthesis systems is anticipated to be a promising strategy to expedite the development of potent delivery systems.http://www.sciencedirect.com/science/article/pii/S2773041724000143 |
| spellingShingle | Zhigang Wang Yufei Yan Rui Li Ying Zhu Gen Yang Artificially engineered vesicular vehicles for targeted therapy Extracellular Vesicle |
| title | Artificially engineered vesicular vehicles for targeted therapy |
| title_full | Artificially engineered vesicular vehicles for targeted therapy |
| title_fullStr | Artificially engineered vesicular vehicles for targeted therapy |
| title_full_unstemmed | Artificially engineered vesicular vehicles for targeted therapy |
| title_short | Artificially engineered vesicular vehicles for targeted therapy |
| title_sort | artificially engineered vesicular vehicles for targeted therapy |
| url | http://www.sciencedirect.com/science/article/pii/S2773041724000143 |
| work_keys_str_mv | AT zhigangwang artificiallyengineeredvesicularvehiclesfortargetedtherapy AT yufeiyan artificiallyengineeredvesicularvehiclesfortargetedtherapy AT ruili artificiallyengineeredvesicularvehiclesfortargetedtherapy AT yingzhu artificiallyengineeredvesicularvehiclesfortargetedtherapy AT genyang artificiallyengineeredvesicularvehiclesfortargetedtherapy |